---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-352727"
form_type: "8-K"
ticker: "INAB"
cik: "0001740279"
company_name: "IN8BIO, INC."
filed_at: "2021-12-09T23:59:59+00:00"
generated_at: "2026-06-28T02:30:49.782290+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# IN8bio appoints Kate Rochlin as Chief Operating Officer effective Dec 1, 2021

## Summary
- Kate Rochlin, Ph.D. appointed COO; will receive $400,000 base salary and 40% bonus eligibility.
- Rochlin previously served as VP, Operations and Innovation at IN8bio since December 2020.
- She holds a Ph.D. in Cell and Developmental Biology from Weill Cornell and a B.A. from University of Pennsylvania.
- No related-party transactions disclosed with the company.

## SEC filing metadata
- accession: 0001193125-21-352727
- form_type: 8-K
- ticker: INAB
- cik: 0001740279
- company_name: IN8BIO, INC.
- filed_at: 2021-12-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1740279/000119312521352727/0001193125-21-352727-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1740279/000119312521352727/d250286d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-352727
- JSON: https://secwatch.observer/filing/0001193125-21-352727.json
- Plain text: https://secwatch.observer/filing/0001193125-21-352727.txt

## Key facts
- Executive change
  Kate Rochlin was appointed as Chief Operating Officer at IN8BIO, INC..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: announced that the Board of Directors had appointed Kate Rochlin, Ph.D. as the Company’s Chief Operating Officer, effective as of December 1, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1740279/000119312521352727/0001193125-21-352727-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.